Trial Profile
A study evaluating effect of metabolic parameters on hepatic dysfunction in Chinese patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 20 Feb 2018 New trial record
- 01 Feb 2018 Results published in the Diabetes Therapy